SE8605459L - Ny celltillvextreglerande faktor - Google Patents

Ny celltillvextreglerande faktor

Info

Publication number
SE8605459L
SE8605459L SE8605459A SE8605459A SE8605459L SE 8605459 L SE8605459 L SE 8605459L SE 8605459 A SE8605459 A SE 8605459A SE 8605459 A SE8605459 A SE 8605459A SE 8605459 L SE8605459 L SE 8605459L
Authority
SE
Sweden
Prior art keywords
cell lines
cell growth
human
pbls
new cell
Prior art date
Application number
SE8605459A
Other languages
Unknown language ( )
English (en)
Other versions
SE8605459D0 (sv
SE505059C2 (sv
Inventor
J M Zarling
M Shoyab
H Marquardt
M B Hanson
M N Lioubin
T J Brown
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of SE8605459D0 publication Critical patent/SE8605459D0/sv
Publication of SE8605459L publication Critical patent/SE8605459L/sv
Publication of SE505059C2 publication Critical patent/SE505059C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE8605459A 1985-12-20 1986-12-18 Förfarande för celltillväxtreglerande faktorer samt antikroppar reaktiva med dessa SE505059C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81123585A 1985-12-20 1985-12-20
US93528386A 1986-11-26 1986-11-26

Publications (3)

Publication Number Publication Date
SE8605459D0 SE8605459D0 (sv) 1986-12-18
SE8605459L true SE8605459L (sv) 1987-06-21
SE505059C2 SE505059C2 (sv) 1997-06-16

Family

ID=27123452

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8605459A SE505059C2 (sv) 1985-12-20 1986-12-18 Förfarande för celltillväxtreglerande faktorer samt antikroppar reaktiva med dessa

Country Status (29)

Country Link
JP (1) JP2559035B2 (sv)
KR (1) KR920005920B1 (sv)
CN (1) CN1017626B (sv)
AT (1) AT400444B (sv)
AU (2) AU601168B2 (sv)
BE (1) BE905957A (sv)
CA (1) CA1340296C (sv)
CH (1) CH675727A5 (sv)
CY (1) CY1608A (sv)
DE (2) DE3643428A1 (sv)
DK (1) DK174094B1 (sv)
ES (1) ES2003180A6 (sv)
FI (1) FI91484C (sv)
FR (1) FR2597108B1 (sv)
GB (1) GB2185485B (sv)
GR (1) GR862936B (sv)
HK (1) HK65691A (sv)
HU (1) HU210694B (sv)
IE (1) IE59415B1 (sv)
IL (1) IL81017A (sv)
IT (1) IT1213428B (sv)
LU (1) LU86718A1 (sv)
NL (1) NL8603209A (sv)
NO (1) NO174556C (sv)
NZ (1) NZ218634A (sv)
OA (1) OA08494A (sv)
PT (1) PT83986B (sv)
SE (1) SE505059C2 (sv)
SG (1) SG60891G (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
US5681930A (en) * 1985-12-20 1997-10-28 Bristol-Myers Squibb Company Anti-oncostatin M monoclonal antibodies
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
IL97622A (en) * 1990-03-29 1997-06-10 Oncogen Limited Partnership Se Monoclonal antibodies that inhibit growth of kaposi's sarcoma
IL97623A (en) * 1990-03-29 1996-01-19 Bristol Myers Squibb Co Monoclonal antibodies against oncostatin M, their preparation and pharmaceutical preparations containing them
WO1992002556A1 (en) * 1990-08-02 1992-02-20 Michael Valentine Agrez Human colon cancer cell-derived fibroblast elongation factor
CZ195193A3 (en) * 1992-09-25 1994-04-13 Lilly Co Eli Modified factor-4 of blood platelets, process of its preparation and pharmaceutical preparation in which it is comprised

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
NO174556C (no) 1994-05-25
LU86718A1 (fr) 1988-07-14
ATA340686A (de) 1995-05-15
JP2559035B2 (ja) 1996-11-27
SE8605459D0 (sv) 1986-12-18
IE863345L (en) 1987-06-20
DE3645095C2 (de) 1993-11-18
HU210694B (en) 1995-06-28
GR862936B (en) 1987-10-28
FI91484B (sv) 1994-03-31
SE505059C2 (sv) 1997-06-16
ES2003180A6 (es) 1988-10-16
CN86108955A (zh) 1987-12-02
GB8629997D0 (en) 1987-01-28
JPS62236498A (ja) 1987-10-16
GB2185485B (en) 1990-07-04
CN1017626B (zh) 1992-07-29
AU6660886A (en) 1987-06-25
NO865178D0 (no) 1986-12-19
HUT43103A (en) 1987-09-28
IL81017A (en) 1993-01-14
FI865156A (sv) 1987-06-21
FI865156A0 (sv) 1986-12-17
HK65691A (en) 1991-08-23
KR870005645A (ko) 1987-07-06
IL81017A0 (en) 1987-03-31
NO174556B (no) 1994-02-14
DK615386A (da) 1987-06-21
AU6776590A (en) 1991-03-14
OA08494A (fr) 1988-07-29
DE3643428C2 (sv) 1990-08-23
SG60891G (en) 1991-08-23
PT83986A (en) 1987-01-01
KR920005920B1 (ko) 1992-07-24
DE3643428A1 (de) 1987-09-24
DK174094B1 (da) 2002-06-10
NZ218634A (en) 1991-06-25
FI91484C (sv) 1994-07-11
AU639048B2 (en) 1993-07-15
NL8603209A (nl) 1987-07-16
AT400444B (de) 1995-12-27
GB2185485A (en) 1987-07-22
CH675727A5 (sv) 1990-10-31
PT83986B (pt) 1989-07-31
IT8622787A0 (it) 1986-12-19
CA1340296C (en) 1998-12-29
IT1213428B (it) 1989-12-20
DK615386D0 (da) 1986-12-18
BE905957A (fr) 1987-06-17
FR2597108A1 (fr) 1987-10-16
NO865178L (no) 1987-06-22
AU601168B2 (en) 1990-09-06
IE59415B1 (en) 1994-02-23
CY1608A (en) 1992-04-03
FR2597108B1 (fr) 1991-02-15

Similar Documents

Publication Publication Date Title
Schröder et al. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.
Seigel et al. Gene for T-cell growth factor: location on human chromosome 4q and feline chromosome B1
ATE65798T1 (de) Menschlicher granuloxcyt-koloniestimulierungsfaktor.
ATE153382T1 (de) Rekombinantes dns-verfahren und wirtszellen
DK163187C (da) Fremgangsmaader til fremstilling af humant immuninterferon (gamma-interferon) samt dna-fragmenter, rekombinante klonings- og udtrykkelsesvektorer og rekombinante mikroorganismer og cellekulturer til anvendelse herved
IL118201A0 (en) Erythropoietin free of animal proteins processes for production and use thereof
BE887529A (fr) Polypeptide preparer, par voie microbiologique avec sequence d'informations genetiques, microorganismes contenant ces informations genetiques et leur procedes de preparation
AU682140B2 (en) Multidrug resistance gene
SE9002589D0 (sv) Neutrofil-aktiverande peptid-2
DE3688900D1 (de) Expression von protein c.
SE8605459L (sv) Ny celltillvextreglerande faktor
NO177270C (no) Fremg. for fremstilling av terapeutisk aktive, humane granulocytt-makrofag-"kolonistimulerende"-faktorproteiner (GM-CSF), bakteriell ekspresjonvektor som er i stand til å uttrykke GM-CSF samt bakteriecelle inneholdende vektoren
FI863971A (fi) Farmaceutisk komposition anvaendbar vid behandling av leukopenia.
EP0260404A3 (en) Amylolytic enzymes producing microorganisms constructed by recombinant dna technology and their use for fermentation processes
KR900702009A (ko) 인체 a형 모노아민 옥시다제를 코오딩 하는 dna
AU7378087A (en) Interleukin-2 induced antineoplastic peptide
ES8700694A1 (es) Un procedimiento para producir un polipeptido de interferon hibrido antivirico y antiproliferante
ES2002164A6 (es) Un metodo para producir un polipeptido o una gicoproteina que tiene una actividad de factor estimulante de colonias de granulocitos humanos.
DE3685517D1 (de) Klonierung und expression von delta-endotoxin-genen von bacillus thuringiensis in bakterienzellen und daraus gewonnene produkte.
CA2051085A1 (en) Expression plasmids
ES8801944A1 (es) Procedimiento de preparar substancias activas antitumor
ES8705466A1 (es) Un metodo para la preparacion del factor nkbs regulador del cancer humano.
MY106737A (en) Methods for increasing numbers of neutrophils, for inducing maturation of myeloid cells with interleukin-4 and purifying interleukin-4.

Legal Events

Date Code Title Description
NUG Patent has lapsed